Associate Director, Scientific Applications, Sample Technologies Development, Qiagen GmbH
Martin Schlumpberger has a Ph.D. in chemistry and more than 20 years of experience working in genetics and molecular biology. He did his postdoctoral fellowship at the Institute of Neurodegenerative diseases at UCSF. He has been at QIAGEN for over 13 years developing new strategies and products, both manual and automated, to isolate nucleic acids from a wide variety of samples, including extracellular RNA and miRNA from serum and plasma, exosomal RNA, as well as intact exosomes and other extracellular vesicles (EVs). He started as a research scientist and is currently an Associate Director in the Sample Technology Development group.